Trial Profile
Open, Multicenter, Randomized Clinical Trial in Patients With Moderate-Severe Psoriasis (PASI > 10) to Compare the Efficacy of Mycophenolate Mofetil Versus Cyclosporine A.
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 16 Jan 2017
Price :
$35
*
At a glance
- Drugs Mycophenolate mofetil (Primary) ; Ciclosporin
- Indications Psoriasis
- Focus Therapeutic Use
- 26 Sep 2009 New trial record.